Overview and Scope
Specimen Validity Testing (SVT) is a process used to assess the integrity and validity of biological specimens, such as urine, blood, saliva, or hair samples, collected for drug testing or clinical analysis. SVT examines various parameters such as pH, creatinine levels, specific gravity, and the presence of common masking agents such as oxidizing adulterants, nitrites, glutaraldehyde, and pyridinium chlorochromate.
Sizing and Forecast
The specimen validity testing market size has grown strongly in recent years. It will grow from $3.37 billion in 2023 to $3.68 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing drug adoption, increased drug screening, stringent regulations, increased alcohol use, and integration of point-of-care testing.
The specimen validity testing market size is expected to see strong growth in the next few years. It will grow to $5.27 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to rising demand for workplace drug testing, growing adoption of oral fluid testing, rise in research and development operations, rising usage of SVTand expanding applications in pain management. Major trends in the forecast period include technological advancements, integration of artificial intelligence for result interpretation, product innovations, increasing partnerships, and the development of portable testing devices for on-the-go monitoring.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/specimen-validity-testing-global-market-report
Segmentation & Regional Insights
The specimen validity testing market covered in this report is segmented –
1) By Product And Service: Products, Service
2) By Testing Type: Laboratory Testing, Rapid Or Point-Of-Care Testing
3) By End-User: Drug Rehabilitation Centers, Drug Screening Laboratories, Pain Management Centers, Criminal Justice And Law Enforcement Agencies, Other End-Users
North America was the largest region in the specimen validity testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specimen validity testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15673&type=smp
Major Driver Impacting Market Growth
The increased drug abuse is expected to propel the growth of the specimen validity testing market going forward. Drug abuse refers to the customary, excessive, or inappropriate use of legal or illegal substances for non-medical purposes. Drug abuse is increasing due to several interconnected factors, such as the opioid habit, developing mental health issues, barriers to treatment and support resources, and cultural depictions. SVT methods are developed to identify the presence of impurities and compounds by examining several parameters such as pH, specific gravity, creatinine content, and temperature. For instance, in October 2023, according to the Office for Health Improvement and Disparities, a UK-based government department, adult contacts with drug and alcohol programs rose from April 2021 to March 2022, totaling 0.29 million interactions, up from 0.28 million the year prior. Additionally, in May 2022, according to the Centers for Disease Control and Prevention, a US-based government agency, opioid overdose deaths in the USA increased by 15% from 70,029 in 2020 to 80,816 in 2021. Therefore, the increased drug abuse is expected to propel the growth of the specimen validity testing market.
Key Industry Players
Major companies operating in the specimen validity testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers , Medline Industries Inc., Becton, Dickinson and Company, Laboratory Corporation, Quest Diagnostics Incorporated, Alere Inc., Clinical Reference Laboratory Inc., Precision Diagnostics, ACM Global Laboratories, Millennium Health, Omega Laboratories Inc., Dominion Diagnostics, CannAmm, Sciteck Inc., Starplex Scientific Inc., Vision Diagnostics Inc., Premier Biotech Inc., Alfa Scientific Designs, Express Diagnostics, American Bio Medica Corporation, Titan Biotech Ltd., SureHire, Miraclean Technology Co. Ltd
The specimen validity testing market report table of contents includes:
- Executive Summary
- Specimen Validity Testing Market Characteristics
- Specimen Validity Testing Market Trends And Strategies
- Specimen Validity Testing Market – Macro Economic Scenario
- Global Specimen Validity Testing Market Size and Growth
- Specimen Validity Testing Market Segmentation
- Specimen Validity Testing Market Regional And Country Analysis
…………..
- Key Mergers And Acquisitions In The Specimen Validity Testing Market
- Specimen Validity Testing Market Future Outlook and Potential Analysis
- Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Specimen Validity Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Specimen Validity Testing Market, Segmentation By Testing Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Specimen Validity Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
……………….
Table 74: Thermo Fisher Scientific Inc. Financial Performance
Table 75: Abbott Laboratories Financial Performance
Table 76: Danaher Corporation Financial Performance
Table 77: Siemens Healthineers Financial Performance
Table 78: Medline Industries Inc. Financial Performance
Explore the trending research reports from TBRC:
https://goodprnews.com/direct-to-consumer-dtc-laboratory-testing-market-size/
https://topprnews.com/anthrax-vaccine-market-growth/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
